Assessment of reactogenicity, safety and immunogenicity of the domestic vaccine «Encevir®» with the reduced antigenic load in the immunization of children aged 3-17 years accordingly to routine scheduled vaccination (report 2) | Zendy

И В Фельдблюм | Zendy; I. A. Okuneva | Zendy; Т. В. Данилина | Zendy; M. G. Мenshikova | Zendy; К. А. Павроз | Zendy; Д. М. Трофимов | Zendy; А. Е. Ершов | Zendy

Open Access

Assessment of reactogenicity, safety and immunogenicity of the domestic vaccine «Encevir®» with the reduced antigenic load in the immunization of children aged 3-17 years accordingly to routine scheduled vaccination (report 2)

Author(s) -

И В Фельдблюм,

I. A. Okuneva,

Т. В. Данилина,

M. G. Мenshikova,

К. А. Павроз,

Д. М. Трофимов,

А. Е. Ершов

Publication year - 2015

Publication title -

epidemiology and infectious diseases

Language(s) - English

Resource type - Journals

eISSN - 2411-3026

pISSN - 1560-9529

DOI - 10.17816/eid40871

Subject(s) - reactogenicity , immunogenicity , medicine , immunization , vaccination , vaccination schedule , antigen , virology , immunology

The article presents the results of an open comparative randomized clinical study on the assessment of the reactogenicity, safety and immunogenicity of the domestic vaccine "EntseVir®" with reduced antigenic load in immunization of children aged 3 to 17 years on the schedule for 0-60 days. The vaccine is characterized by the low reactogenicity, high safety profile and immunogenicity. On main indices, it is not inferior to foreign vaccine «FSME-Immun Inject / Junior».

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research